Evidence map›Paper›PMID 42720900›Full record

ArticleCardiovascular intervention and therapeutics2026

Ten-year outcomes after percutaneous coronary intervention with drug-eluting stents for bifurcation lesions: insights from the DECADE cooperation.

Constantin Kuna, Laura Huber, J J Coughlan, Dik Heg, Fiorenzo Simonetti, Lorenz Räber, Karl-Ludwig Laugwitz, Stephan Windecker, Adnan Kastrati, Salvatore Cassese

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular intervention and therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Constantin KunaKlinik für Herz- und Kreislauferkrankungen, TUM Klinikum Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse, 36, 81247, Munich, Germany.
Laura HuberKlinik für Herz- und Kreislauferkrankungen, TUM Klinikum Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse, 36, 81247, Munich, Germany.
J J CoughlanDepartment of Cardiology and Cardiovascular Research Institute, Mater Private Network, Dublin, Ireland.
Dik HegDepartment of Clinical Research, University of Bern, Bern, Switzerland.
Fiorenzo SimonettiKlinik für Herz- und Kreislauferkrankungen, TUM Klinikum Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse, 36, 81247, Munich, Germany.
Lorenz RäberDepartment of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Karl-Ludwig LaugwitzMedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Stephan WindeckerDepartment of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
Adnan KastratiKlinik für Herz- und Kreislauferkrankungen, TUM Klinikum Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse, 36, 81247, Munich, Germany.
Salvatore CasseseKlinik für Herz- und Kreislauferkrankungen, TUM Klinikum Deutsches Herzzentrum, Technische Universität München, Lazarettstrasse, 36, 81247, Munich, Germany. cassese@dhm.mhn.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients treated with percutaneous coronary intervention (PCI) for bifurcation lesions have an increased risk of recurrent cardiac events. However, there are limited data on long-term outcomes after PCI with drug-eluting stents (DES) for bifurcation lesions. We sought to compare the long-term outcomes after DES PCI for bifurcation and non-bifurcation lesions among patients included in the Adverse Events and Coronary Artery Disease Progression (DECADE) cooperation, a pooled analysis of individual patient data from randomized controlled trials on DES platforms with a follow-up of 10 years. In the current analysis, patients undergoing PCI with DES were grouped according to whether the treated lesion was classified as a bifurcation or not. The main outcomes were cardiovascular death, myocardial infarction (MI) and target lesion revascularization (TLR) through to 10 years after PCI. Among the total of 6,617 patients included in this study, 1,580 patients underwent PCI of at least one bifurcation lesion and 5,037 patients underwent PCI of non-bifurcation lesions. Through to 10-year follow-up, cardiovascular death (adjusted hazard ratio [HR

Indexed as

BifurcationCoronary artery diseasePercutaneous coronary intervention, drug-eluting stent

Identifiers

PMID42720900

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.